Guangzhou Boji Medical Biotechnological co.,Ltd.
Guangzhou Boji Medical Biotechnological co.,Ltd.(Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Guangzhou Boji Medical Biotechnological co.,Ltd.
Guangzhou Boji Medical Biotechnological co.,Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Guangzhou Boji Medical Biotechnological co.,Ltd.
Guangzhou Boji Medical Biotechnological co.,Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Guangzhou Boji Medical Biotechnological co.,Ltd.
Guangzhou Boji Medical Biotechnological co.,Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Guangzhou Boji Medical Biotechnological co.,Ltd.
Guangzhou Boji Medical Biotechnological co.,Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Guangzhou Boji Medical Biotechnological co.,Ltd.
Guangzhou Boji Medical Biotechnological co.,Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Guangzhou Boji Medical Biotechnological co.,Ltd.
Guangzhou Boji Medical Biotechnological co.,Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
Guangzhou Boji Medical Biotechnological co.,Ltd
Guangzhou Boji Medical Biotechnological co.,Ltd (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Guangzhou Boji Medical Biotechnological co.,Ltd
Guangzhou Boji Medical Biotechnological co.,Ltd (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Company News
Many famous professionals gathered for the meeting! Platinum Member-Boji Night was held yesterday in Guangzhou!
作者:广州博济医药 时间:2021-01-07 来源:广州博济医药

On December 18, the "Platinum Member-Boji Night" - "The New Drugs Story" sharing salon and the 18th anniversary appreciation dinner hosted

by Guangdong Bio-Pharmaceutical Innovation Technology Association and organized by Guangzhou Boji Medical biotechnological co.,Ltd., was

held at Guangzhou Science City Convention Center. More than 100 leaders from the biopharmaceutical industry of Guangdong Province

attended this salon dinner andshared the occasion.





  • Phone:400-0020-628
  • Address:7th Floor, Building A, Vanke Cloud Plaza, 1933 Huaguan Road, Tianhe District, Guangzhou
Copyright © Boji Medical Technology Co., Ltd. All Rights Reserved 粤ICP备13039920号 (粤)—非经营性—2020-0084 Powered by vancheer
Copyright © Boji Medical Technology Co., Ltd. All Rights Reserved 粤ICP备13039920号 (粤)—非经营性—2020-0084 Powered by vancheer